DECHENG CAPITAL MANAGEMENT III (CAYMAN), LLC – Mersana Therapeutics, Inc. Transaction History
DECHENG CAPITAL MANAGEMENT III (CAYMAN), LLC portfolio value:
$6.11M
portfolio value
DECHENG CAPITAL MANAGEMENT III (CAYMAN), LLC quarter portfolio value change:
+46.32%
quarter
Mersana Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | 0.00% | 0 shares | 1.93M | $6.76 | 904.26K | |
| Q2 2022 | share | 0.00% | 0 shares | 570K | $4.62 | 904.26K | |
| Q1 2022 | share | Increase | 0.00% | 904.26K shares | 3.60M | $3.99 | 904.26K |